COMMUNIQUÉS West-GlobeNewswire

Teknova to Report Second Quarter 2026 Financial Results on August 5, 2026
22/07/2026
HOLLISTER, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, [...]
Egg Medical Declares New Era in Fluoroscopy Lab Safety Following Joint Consensus Statement
22/07/2026
As major medical societies call for mandatory adoption of Enhanced Radiation Protection Devices (ERPDs), the EggNest® Complete system emerges as the definitive solution to protect the entire clinical team MINNEAPOLIS, [...]
Serenity Medical’s River Stent™ Demonstrates Sustained 4- to 5-Year Benefits in Patients with Idiopathic Intracranial Hypertension (IIH), Presented at SNIS Annual Meeting in Late-Breaking Session
22/07/2026
Long-term data reinforce durability of venous sinus stenting as an evidence-backed, FDA-approved treatment option MAPLE GROVE, Minn., July 22, 2026 (GLOBE NEWSWIRE) -- Serenity Medical , a NeuroTechnology Investors (NTI [...]
The Healing Well Method Launches Chronic Illness Education Initiative to Empower Women with Chronic Illness
22/07/2026
Fort Lauderdale, FLORIDA, July 22, 2026 (GLOBE NEWSWIRE) -- The Healing Well Method today announced the launch of its Chronic Illness Education Initiative, a new educational program designed to help women living with [...]
Coherus Oncology to Report Second Quarter 2026 Financial Results on August 5, 2026
22/07/2026
REDWOOD CITY, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc . (Nasdaq: CHRS), today announced that its second quarter 2026 financial results will be released on Wednesday, August 5, 2026. Starting at 5 [...]
NexTel Medical Corp. Amends Previously Announced Acquisition to Acquire Island 40 Group and Full Subsidiary Platform
22/07/2026
Revised transaction expands NexTel’s acquisition from JumpstartRx and NuevistraMed to Island 40 Group’s broader growth platform, adding health services, pharmaceutical access, lab testing, institutional partnerships, [...]
Spryte Medical Completes INSYTE Trial Enrollment
22/07/2026
FDA-approved IDE study of the company’s neuro-optical coherence tomography nOCT™ Imaging System completes enrollment, representing a significant step toward regulatory submission for diagnostic use in intracranial [...]
Ipsen - Corrective statement amending the monthly disclosure of the total number of shares and voting rights as of June 30, 2026
22/07/2026
CORRECTIVE STATEMENT Corrective statement amending the monthly disclosure of the total number of shares and voting rights as of June 30, 2026, published on July 9, 2026 Paris, July 22, 2026 This corrective statement is [...]
Ipsen - Déclaration rectificative corrigeant la déclaration mensuelle du nombre total d'actions et de droits de vote au 30 juin 2026
22/07/2026
DÉCLARATION RECTIFICATIVE Déclaration rectificative corrigeant la déclaration mensuelle du nombre total d'actions et de droits de vote au 30 juin 2026, publiée le 9 juillet 2026 Paris, le 22 juillet 2026 La présente [...]
OKYO Pharma Announces Purchase of Shares by Chairman
22/07/2026
LONDON and NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain ( [...]
Valneva to Report First Half 2026 Consolidated Financial Results on August 13, 2026
22/07/2026
Lyon (France), July 22, 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it will report its first half 2026 financial results on Thursday, August 13, 2026. The [...]
Valneva publiera ses résultats financiers consolidés du premier semestre le 13 août 2026
22/07/2026
Lyon (France), le 22 juillet 2026 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui qu’elle publiera ses résultats financiers du premier semestre le jeudi 13 [...]
One Tulsa Physician Manages Hormone Therapy, Peptides and GLP-1 Weight Loss
22/07/2026
Results Medical Aesthetics & Wellness, a physician-led clinic in Tulsa, prescribes hormone replacement therapy only after comprehensive lab testing establishes a metabolic baseline. Laura Bilbruck, MD, an Oklahoma- [...]
RAMSAY SANTE : Press Release - Refinancing new steps forward
22/07/2026
PRESS RELEASE Paris, 22 nd July 2026 New steps in connection with Ramsay Santé contemplated free-float expansion: Ramsay Santé successfully completes its senior debt refinancing and convenes a Capital Markets Day on 17 [...]
RAMSAY SANTE : communiqué de presse - refinancement et prochaines étapes
22/07/2026
COMMUNIQUÉ DE PRESSE Paris, le 22 juillet 2026 Ramsay Santé franchit de nouvelles étapes dans le cadre de l’élargissement envisagé de son flottant : succès du refinancement de sa dette senior et organisation d’un [...]
FDA Takes Further Steps to Remove Outdated Authorizations for Color Additives in Food
22/07/2026
Silver Spring, MD, July 22, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today announced two actions targeting petroleum-based color additives in food, continuing the agency’s broader efforts to Make [...]
Guidelight Health Opens Eighth Massachusetts Location, Expanding Access to Structured Mental Health Care
22/07/2026
New Andover location and statewide virtual IOP extend timely, evidence-based care across the Commonwealth ANDOVER, Mass., July 22, 2026 (GLOBE NEWSWIRE) -- Guidelight Health, a leader in evidence-based mental health [...]
SoldierStrong Donates Two Real® Immersive Systems to Palo Alto VA to Advance Veteran Rehabilitation
22/07/2026
STAMFORD, Conn., July 22, 2026 (GLOBE NEWSWIRE) -- SoldierStrong, a national nonprofit committed to donating revolutionary medical technology to assist injured veterans in taking their next steps forward in life after [...]
OKYO Pharma Announces Purchase of Shares by Chief Development Officer and Director
22/07/2026
LONDON and NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO ), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain ( [...]

Pages